Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder
- PMID: 32056928
- DOI: 10.1016/j.jad.2020.01.125
Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder
Abstract
Background: Evidence suggests that depression is correlated with immune-inflammatory responses, and efforts have been made to identify the relationships between depression and inflammatory markers. This study investigated the level of cytokines before and after treatment for major depressive disorder (MDD) in medication-naïve adolescents with first-episode MDD and compared them with the levels in healthy adolescents. The relationship between cytokine levels and the severity of depressive symptoms was also examined.
Methods: Twenty-five adolescents with MDD and 25 healthy controls aged 13 to 18 years were included in the study. Blood samples were obtained, and depression severity was assessed twice in the MDD group before and after treatment and once in the healthy group.
Results: When compared with healthy controls, adolescents with MDD had lower levels of interleukin 2 (IL-2), interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α) and IL-10 before treatment and higher levels of IL-2, IFN-γ, and IL-10 after treatment. In addition, the IFN-γ levels correlated with depressive severity scores in both the Children's Depression Inventory (CDI) and Hamilton Depression Rating Scale (HDRS). The IL-10 level correlated with depressive severity only on the HDRS.
Limitations: The sample size was small, and the 12-week follow-up time after treatment was relatively short.
Conclusion: IL-2, IFN-γ, TNF-α, and IL-10 levels in medication-naïve adolescents with first-episode MDD differed from those in healthy controls. The levels of IL-2, IFN-γ, and IL-10 were altered after antidepressant treatment. Further, the IFN-γ and IL-10 levels correlated with the severity of depressive symptoms.
Keywords: Adolescent; Cytokine; Depression; First-episode; Inflammation; Medication-naïve.
Copyright © 2020. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
[Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):310-315. doi: 10.12182/20230360204. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36949691 Free PMC article. Chinese.
-
The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder.BMC Psychiatry. 2024 Apr 16;24(1):285. doi: 10.1186/s12888-024-05724-0. BMC Psychiatry. 2024. PMID: 38627683 Free PMC article. Clinical Trial.
-
Faster speed of onset of the depressive episode is associated with lower cytokine serum levels (IL-2, -4, -6, -10, TNF-α and IFN-γ) in patients with major depression.J Psychiatr Res. 2021 Sep;141:287-292. doi: 10.1016/j.jpsychires.2021.06.033. Epub 2021 Jul 8. J Psychiatr Res. 2021. PMID: 34271459
-
The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review.J Affect Disord. 2020 Jul 1;272:1-7. doi: 10.1016/j.jad.2020.03.145. Epub 2020 Apr 5. J Affect Disord. 2020. PMID: 32379599 Review.
-
[Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].Encephale. 2017 Feb;43(1):62-68. doi: 10.1016/j.encep.2016.02.017. Epub 2016 Jul 21. Encephale. 2017. PMID: 27452149 Review. French.
Cited by
-
Cytokine levels reflect tic symptoms more prominently during mild phases.BMC Neurosci. 2023 Oct 31;24(1):57. doi: 10.1186/s12868-023-00830-3. BMC Neurosci. 2023. PMID: 37907857 Free PMC article.
-
Genetically predicted circulating levels of cytokines and the risk of depression: a bidirectional Mendelian-randomization study.Front Genet. 2023 Aug 4;14:1242614. doi: 10.3389/fgene.2023.1242614. eCollection 2023. Front Genet. 2023. PMID: 37600668 Free PMC article.
-
Prospective study on Maresin-1 and cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.Front Psychiatry. 2023 Mar 15;14:1132791. doi: 10.3389/fpsyt.2023.1132791. eCollection 2023. Front Psychiatry. 2023. PMID: 37009097 Free PMC article.
-
Evaluation of Inflammatory Response System (IRS) and Compensatory Immune Response System (CIRS) in Adolescent Major Depression.J Inflamm Res. 2022 Oct 26;15:5959-5976. doi: 10.2147/JIR.S387588. eCollection 2022. J Inflamm Res. 2022. PMID: 36303711 Free PMC article.
-
Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder.Front Mol Neurosci. 2022 Aug 24;15:935031. doi: 10.3389/fnmol.2022.935031. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36090246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical